Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Free Report) was the recipient of a large decline in short interest in May. As of May 15th, there was short interest totalling 47,500 shares, a decline of 91.6% from the April 30th total of 568,300 shares. Based on an average daily volume of 1,410,000 shares, the days-to-cover ratio […]
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Free Report) CEO George K. Ng purchased 10,000 shares of Processa Pharmaceuticals stock in a transaction that occurred on Tuesday, January 30th. The stock was acquired at an average price of $2.70 per share, with a total value of $27,000.00. Following the transaction, the chief executive officer now owns […]
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Director Justin W. Yorke Purchases 8,000 Shares of Stock themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Rating) shares shot up 2.6% during mid-day trading on Tuesday . The company traded as high as $0.57 and last traded at $0.56. 35,908 shares changed hands during mid-day trading, a decline of 82% from the average session volume of 201,922 shares. The stock had previously closed at $0.55. […]
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Rating) shares shot up 2.6% during mid-day trading on Tuesday . The company traded as high as $0.57 and last traded at $0.56. 35,908 shares changed hands during mid-day trading, a decline of 82% from the average session volume of 201,922 shares. The stock had previously closed at $0.55. […]